RESONIUM A POWDER

Indications

• Hyperkalemia
• Management of elevated potassium levels in patients with renal impairment
• Adjunct therapy in certain cases of heart failure or diuretic use

Dosage

Children: Refer to specific guidelines or clinical protocols for dosing information.

Adults: Refer to specific guidelines or clinical protocols for dosing information.

Mechanism of action

Polystyrene sulfonate functions as a cation-exchange resin. It binds potassium ions in the gastrointestinal tract and exchanges them for sodium ions. This process reduces the serum potassium concentration by facilitating its excretion through fecal elimination.

Pharmacodynamics

The pharmacodynamic effect of polystyrene sulfonate is primarily the lowering of serum potassium levels. The onset of action can vary, but the effects generally occur within 1 to 2 hours after administration. The duration of action may last several hours, depending on the dosage and the patient's gastrointestinal transit time.

Pharmacokinetics

Polystyrene sulfonate is not absorbed systemically; it remains within the gastrointestinal tract. Its effects are local, and it is excreted primarily through feces. The resin is not metabolized by the body, and its elimination is related to the bowel transit time.

Adverse effects

• Gastrointestinal disturbances
• Constipation
• Nausea
• Vomiting

Precautions

• Use with caution in patients with pre-existing gastrointestinal disorders
• Monitor electrolyte levels during treatment
• Ensure adequate hydration

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

It is unknown whether this drug is excreted in human milk. Use with caution.

Storage

Store at room temperature, away from moisture and heat.

Formulations

• Oral suspension
• Powder for oral solution

Mechanism of action

Sulphonates exert their effects primarily through the inhibition of certain enzymes or pathways involved in metabolic processes. They may interact with cellular receptors or transporters, leading to alterations in ion transport, enzyme activity, and cellular signaling.

Pharmacodynamics

The pharmacodynamics of sulphonates is largely dependent on their specific structure and the biological targets they interact with. Generally, they may modulate the activity of neurotransmitters, influence the reactivity of free radicals, or affect cellular signaling pathways, contributing to their therapeutic effects.

Pharmacokinetics

Sulphonates are typically absorbed in the gastrointestinal tract, with variable bioavailability depending on the specific compound. They are metabolized primarily in the liver, with subsequent elimination through renal pathways. The half-life and clearance can vary significantly based on the compound's structure and the individual's physiology.